Aspira Women's Health Inc. (AWH)
NASDAQ: AWH · Real-Time Price · USD
0.0937
-0.0043 (-4.39%)
Apr 15, 2025, 4:00 PM EDT - Market closed
Aspira Women's Health Revenue
In the year 2024, Aspira Women's Health had annual revenue of $9.18M with 0.31% growth. Aspira Women's Health had revenue of $2.35M in the quarter ending December 31, 2024, with 10.28% growth.
Revenue (ttm)
$9.18M
Revenue Growth
+0.31%
P/S Ratio
0.14
Revenue / Employee
$139,121
Employees
66
Market Cap
2.79M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 9.18M | 28.00K | 0.31% |
| Dec 31, 2023 | 9.15M | 970.00K | 11.85% |
| Dec 31, 2022 | 8.18M | 1.37M | 20.14% |
| Dec 31, 2021 | 6.81M | 2.16M | 46.46% |
| Dec 31, 2020 | 4.65M | 113.00K | 2.49% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| UnitedHealth Group | 400.28B |
| Johnson & Johnson | 89.33B |
| Merck & Co. | 64.17B |
| AbbVie | 56.33B |
| AstraZeneca | 54.07B |
| Novartis AG | 51.72B |
| Eli Lilly and Company | 45.04B |
| Thermo Fisher Scientific | 42.88B |
AWH News
- 7 days ago - Aspira Appoints Three New Directors, Executes $2.0 Million Equity Purchase Agreement - Accesswire
- 15 days ago - Aspira Receives $1.5 million Milestone Payment from the ARPA-H Sprint for Women's Health Award - Accesswire
- 19 days ago - Aspira Women's Health Reports Fourth Quarter and Full Year 2024 Financial Results - Accesswire
- 5 weeks ago - Aspira Women's Health Announces Closing of $1.37 Million Private Placement of Convertible Notes - Accesswire
- 2 months ago - Aspira Women's Health Submits Request for Withdrawal of Form S-1 Registration Statement - Accesswire
- 2 months ago - Aspira Women's Health Announces Appointment of Ellen Beausang to the Board of Directors - Accesswire
- 3 months ago - Aspira Women's Health Announces the Appointment of Mike Buhle as SVP of Commercial Operations - Accesswire
- 4 months ago - Aspira Women's Health Announces Appointment of Dr. Sandra Milligan as Interim CEO - GlobeNewsWire